All In MedTech

Device Trial Radar · NCT01852084

Hydrophobic Acrylic Toric IOL Designed to Reduce the Effects of Preoperative Corneal Astigmatism

To Evaluate the Safety and Effectiveness of the EnVista® One-Piece Hydrophobic Acrylic Toric IOL Designed to Reduce the Effects of Preoperative Corneal Astigmatism on Postoperative Refraction Following Cataract Surgery

Last checked: Nov 19, 2026Latest source record: Sep 16, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 191 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

191

Actual

Start

Mar 6, 2013

Primary completion

Jul 18, 2016

Study completion Dec 2016

Sponsor

Lead sponsor
Bausch & Lomb IncorporatedNot on our public-company list
Sponsor type
Industry
First posted
May 13, 2013

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The investigational enVista IOL, Model MX60Tis equipped with toric optics and axis marks on the posterior surface to minimize the possibility of surgically induced astigmatism.

Conditions

  • Astigmatism

Interventions

  • enVista® One-Piece Hydrophobic Acrylic Toric IOLDevice

    Test lens having a toric cylinder power of either 1.25 diopters (D), 2.00 D, or 2.75 D

  • enVista control lensDevice

    Spherical Control lens

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean Dioptric Change in CylinderTime frame: Baseline, Final Visit (scheduled within window: days 120-180)
  2. Percentage of Participants With Intraocular Lens (IOL) Rotation of Less Than or Equal to Five DegreesTime frame: Form 3 Visit (window: days 30-60), Final Visit (window: days 120-180)
  3. Mean Best-corrected Distance Visual Acuity (BCDVA) at Final VisitTime frame: Final Visit (scheduled within window: days 120-180)

1 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Bausch & Lomb

    Irvine, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.